The hyaluronan receptor CD44, which has also been proposed as a SLGC and GBM subtype marker with significance in tumor progression [60] showed varying expression levels in Western blots, in which high CD44 expression was observed for both SLGC cultures with high and low Sox2 levels (Fig 2C). This evidence concerns the gene CD44 and glioblastoma.